Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital

被引:30
作者
Ehlers, Marthie M. [1 ]
Veldsman, Chrisna [1 ]
Makgotlho, Eddy P. [1 ]
Dove, Michael G. [1 ]
Hoosen, Anwar A. [1 ]
Kock, Marleen M. [1 ]
机构
[1] Univ Pretoria NHLS, Fac Hlth Sci, Dept Med Microbiol, ZA-0001 Pretoria, South Africa
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2009年 / 56卷 / 03期
关键词
extended-spectrum beta-lactamases; cefotaximase; temoniera; sulfhydryl variable; SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; INFECTION; EMERGENCE; ENTEROBACTERIACEAE; PREVALENCE; CHALLENGE;
D O I
10.1111/j.1574-695X.2009.00564.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Extended-spectrum beta-lactamases (ESBLs) are considered to be one of the most important antibiotic resistance mechanisms. This study reported the ESBL-producing genes in 53 randomly selected clinical bacterial isolates from the Steve Biko Academic Hospital. The presence of the bla(SHV), bla(TEM) and bla(CTX-M) genes was determined, and the overall prevalence of these genes detected in this study was 87% (46/53) in comparison with the literature; these results were higher when compared with 33% for Escherichia coli in Europe and 0.8% in Denmark for similar pathogens. These research findings indicated that it is crucial to routinely monitor the prevalence of these resistance genes.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 24 条
  • [1] Al-Jasser AM., 2006, KUWAIT MED J, V38, P171, DOI DOI 10.4103/0974-777X.68531
  • [2] Prevalence and significance of a negative extended-spectrum β-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae:: Results from the SENTRY Asia-Pacific surveillance program
    Bell, Jan M.
    Chitsaz, Mohsen
    Turnidge, John D.
    Barton, Mary
    Walters, Luke J.
    Jones, Ronald N.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (05) : 1478 - 1482
  • [3] Extended-spectrum β-lactamases:: A challenge for clinical microbiologists and infection control specialists
    Colodner, R
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2005, 33 (02) : 104 - 107
  • [4] Emergence of enterobactefiaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria
    Eisner, A
    Fagan, EJ
    Feierl, G
    Kessler, HH
    Marth, E
    Livermore, DM
    Woodford, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 785 - 787
  • [5] CTX-M extended-spectrum β-lactamases, Washington State
    Kim, Seonghan
    Hu, Jinxin
    Gautom, Romesh
    Kim, Junyoung
    Lee, Bokkwon
    Boyle, David S.
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 513 - 514
  • [6] First report of the emergence of CTX-M-Type extended-spectrum β-lactamases (ES-BLs) as the predominant ESBL isolated in a US health care Systemdel
    Lewis, James S., II
    Herrera, Monica
    Wickes, Brian
    Patterson, Jan E.
    Jorgensen, James H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) : 4015 - 4021
  • [7] Meyer L., 2007, Southern African Journal of Epidemiology & Infection, V22, P5
  • [8] MEYER L, 2004, S AFR J EPID INFECT, V22, P5
  • [9] Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae
    Monstein, H. -J.
    Ostholm-Balkhed, A.
    Nilsson, M. V.
    Nilsson, M.
    Dornbusch, K.
    Nilsson, L. E.
    [J]. APMIS, 2007, 115 (12) : 1400 - 1408
  • [10] Nosocomial outbreak of CTX-M-15-producing E-coli in Norway
    Naseer, Umaer
    Natas, Olav B.
    Haldorsen, Bjorg C.
    Bue, Berit
    Grundt, Heidi
    Walsh, Timothy R.
    Sundsfjord, Arnfinn
    [J]. APMIS, 2007, 115 (02) : 120 - 126